Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The 17th International Workshop on Non-Hodgkin Lymphoma (iwNHL) took place on September 6–8, 2019, in Boston, MA.
Leading experts in the field came together to discuss the hot topics in NHL, including T-cell lymphomas, tumor microenvironment, immunotherapy, novel targets & agents, cellular therapy, in addition to a special lecture by Elaine Jaffe celebrating 25 years of the REAL classification.
These webcasts will provide insight into these key themes and will help you consolidate your knowledge of NHL. To view each presentation simply click on its title. Please note that presentations from Session III are not available due to unpublished data.
▶ CD19-specific CAR T-cells for NHL: an overview
David Maloney
▶ CD20-targeted CAR T-cell therapy for lymphoma
Brian Till
▶ Developing and evaluating CAR T-cells for T-cell lymphoma
Max Mamonkin